Nature Communications (Mar 2021)
The prevalence of antibodies to SARS-CoV-2 among blood donors in China
- Le Chang,
- Wangheng Hou,
- Lei Zhao,
- Yali Zhang,
- Yanbin Wang,
- Linfeng Wu,
- Tingting Xu,
- Lilin Wang,
- Juan Wang,
- Jian Ma,
- Lan Wang,
- Junpeng Zhao,
- Jing Xu,
- Juan Dong,
- Ying Yan,
- Ru Yang,
- Yu Li,
- Fei Guo,
- Wenjuan Cheng,
- Yingying Su,
- Jinfeng Zeng,
- Wei Han,
- Tong Cheng,
- Jun Zhang,
- Quan Yuan,
- Ningshao Xia,
- Lunan Wang
Affiliations
- Le Chang
- National Center for Clinical Laboratories, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences
- Wangheng Hou
- State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University
- Lei Zhao
- Department of Laboratory, Wuhan Blood Center
- Yali Zhang
- State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University
- Yanbin Wang
- Blood Screening Laboratory, Hebei Province Blood Center
- Linfeng Wu
- Shenzhen Blood Center
- Tingting Xu
- Department of Laboratory, Wuhan Blood Center
- Lilin Wang
- Shenzhen Blood Center
- Juan Wang
- State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University
- Jian Ma
- State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University
- Lan Wang
- Wuhan Blood Center
- Junpeng Zhao
- Shenzhen Blood Center
- Jing Xu
- Wuhan Blood Center
- Juan Dong
- Department of Laboratory, Wuhan Blood Center
- Ying Yan
- National Center for Clinical Laboratories, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences
- Ru Yang
- Department of Transfusion Research, Wuhan Blood Center
- Yu Li
- Department of Laboratory, Wuhan Blood Center
- Fei Guo
- National Center for Clinical Laboratories, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences
- Wenjuan Cheng
- Department of Laboratory, Wuhan Blood Center
- Yingying Su
- State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University
- Jinfeng Zeng
- Shenzhen Blood Center
- Wei Han
- Blood Screening Laboratory, Hebei Province Blood Center
- Tong Cheng
- State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University
- Jun Zhang
- State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University
- Quan Yuan
- State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University
- Ningshao Xia
- State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University
- Lunan Wang
- National Center for Clinical Laboratories, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences
- DOI
- https://doi.org/10.1038/s41467-021-21503-x
- Journal volume & issue
-
Vol. 12,
no. 1
pp. 1 – 10
Abstract
Here, the authors determine seroprevalence of antibodies to SARS-CoV-2 in healthy blood donors in the cities of Wuhan, Shenzhen, and Shijiazhuang in China between January and April 2020. The age- and sex-standardized SARS-CoV-2 seroprevalence among 18–60 year-old adults is, with 2.66%, the highest in Wuhan.
